491 related articles for article (PubMed ID: 16608370)
21. Targeted delivery in scleroderma fibrosis.
Varrica C; Dias HS; Reis C; Carvalheiro M; Simões S
Autoimmun Rev; 2021 Feb; 20(2):102730. PubMed ID: 33338593
[TBL] [Abstract][Full Text] [Related]
22. [Juvenile localized scleroderma].
Strauss T; Günther C; Brück N
Dermatologie (Heidelb); 2024 Mar; 75(3):208-213. PubMed ID: 38240812
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of scleroderma with PUVA therapy.
Kanekura T; Fukumaru S; Matsushita S; Terasaki K; Mizoguchi S; Kanzaki T
J Dermatol; 1996 Jul; 23(7):455-9. PubMed ID: 8772023
[TBL] [Abstract][Full Text] [Related]
24. [Scleroderma in children].
Frati Munari AC; Culebro Nieves G; Velázquez E; Podoswa G
Bol Med Hosp Infant Mex; 1979; 36(2):201-14. PubMed ID: 758191
[TBL] [Abstract][Full Text] [Related]
25. Phototherapy for scleroderma: biologic rationale, results, and promise.
Fisher GJ; Kang S
Curr Opin Rheumatol; 2002 Nov; 14(6):723-6. PubMed ID: 12410098
[TBL] [Abstract][Full Text] [Related]
26. Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.
Distler O; Cozzio A
Semin Immunopathol; 2016 Jan; 38(1):87-95. PubMed ID: 26577237
[TBL] [Abstract][Full Text] [Related]
27. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
Arif T; Masood Q; Singh J; Hassan I
BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470
[TBL] [Abstract][Full Text] [Related]
28. Systemic and localized scleroderma.
Chung L; Lin J; Furst DE; Fiorentino D
Clin Dermatol; 2006; 24(5):374-92. PubMed ID: 16966019
[TBL] [Abstract][Full Text] [Related]
29. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis.
Falanga V; Medsger TA
J Am Acad Dermatol; 1987 Oct; 17(4):648-56. PubMed ID: 3668010
[TBL] [Abstract][Full Text] [Related]
30. Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma.
Ketpueak T; Chanloung W; Nan KN; Pongsananurak C; Kasitanon N; Louthrenoo W
Clin Rheumatol; 2022 Dec; 41(12):3887-3896. PubMed ID: 36085204
[TBL] [Abstract][Full Text] [Related]
31. Localized scleroderma in childhood is not just a skin disease.
Zulian F; Vallongo C; Woo P; Russo R; Ruperto N; Harper J; Espada G; Corona F; Mukamel M; Vesely R; Musiej-Nowakowska E; Chaitow J; Ros J; Apaz MT; Gerloni V; Mazur-Zielinska H; Nielsen S; Ullman S; Horneff G; Wouters C; Martini G; Cimaz R; Laxer R; Athreya BH;
Arthritis Rheum; 2005 Sep; 52(9):2873-81. PubMed ID: 16142730
[TBL] [Abstract][Full Text] [Related]
32. Penicillamine in systemic sclerosis: a reappraisal.
Sattar MA; Guindi RT; Sugathan TN
Clin Rheumatol; 1990 Dec; 9(4):517-22. PubMed ID: 2088649
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
[TBL] [Abstract][Full Text] [Related]
34. Prospective study to evaluate the clinical and radiological outcome of patients with scleroderma of the face.
Careta MF; Leite Cda C; Cresta F; Albino J; Tsunami M; Romiti R
Autoimmun Rev; 2013 Sep; 12(11):1064-9. PubMed ID: 23791631
[TBL] [Abstract][Full Text] [Related]
35. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.
Fett N
Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160
[TBL] [Abstract][Full Text] [Related]
36. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol].
Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA
Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343
[No Abstract] [Full Text] [Related]
37. Treatment in Juvenile Scleroderma.
Zulian F; Tirelli F
Curr Rheumatol Rep; 2020 Jun; 22(8):45. PubMed ID: 32591919
[TBL] [Abstract][Full Text] [Related]
38. [How I explore ... the skin functional involvement in scleroderma].
Hermanns-Lê T; Piérard-Franchimont C; Piérard GE; André B; De Roover C; Renwart L; Delvenne P
Rev Med Liege; 2013 Mar; 68(3):141-7. PubMed ID: 23614323
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporin in localized and systemic scleroderma--a clinical study.
Wörle B; Hein R; Krieg T; Meurer M
Dermatologica; 1990; 181(3):215-20. PubMed ID: 2269381
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
